Literature DB >> 19032813

Erythrocyte sedimentation rate and C-reactive protein levels are poorly correlated with clinical measures of disease activity in rheumatoid arthritis, systemic lupus erythematosus and osteoarthritis patients.

R T Keenan1, C J Swearingen, Y Yazici.   

Abstract

OBJECTIVE: To determine the patterns and correlation of elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels with outcome measures in rheumatoid arthritis (RA), and compare it to systemic lupus erythematosus (SLE) and osteoarthritis (OA) patients.
METHODS: Brooklyn Outcomes Arthritis Registry Database (BOARD) was analyzed to determine both first visit and mean values of ESR and CRP, along with disease activity measures in each patient. Data were analyzed with descriptive statistics and correlations.
RESULTS: Among all patients half of all (n=377) ESR results were elevated. In RA patients the proportions of having both ESR and CRP elevated, both within normal levels, and only one elevated and the other normal were similar. For all diagnosis, both ESR and CRP have weak positive correlations with disease activity measures measured at first visits. ESR and CRP have a modest positive correlation with each other across all three disease groups.
CONCLUSION: In this cohort of RA, SLE and OA patients, ESR and CRP values were modestly correlated with each other and they were weakly correlated with disease activity measures. These data suggest that another look at the role of ESR and CRP as markers of inflammation in RA patients seen in routine care may be in order.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19032813

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  22 in total

1.  Correlation of the Multi-Biomarker Disease Activity Score With Rheumatoid Arthritis Disease Activity Measures: A Systematic Review and Meta-Analysis.

Authors:  Tate M Johnson; Kyle A Register; Cynthia M Schmidt; James R O'Dell; Ted R Mikuls; Kaleb Michaud; Bryant R England
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-11       Impact factor: 4.794

2.  Neutrophil-to-C3 ratio and neutrophil-to-lymphocyte ratio were associated with disease activity in patients with systemic lupus erythematosus.

Authors:  Jianlin Yu; Tingting Zeng; Yang Wu; Yongjian Tian; Liming Tan; Xinwang Duan; Qiong Wu; Hua Li; Le Yu
Journal:  J Clin Lab Anal       Date:  2018-08-20       Impact factor: 2.352

Review 3.  Autoantibodies and other serological markers in rheumatoid arthritis: predictors of disease activity?

Authors:  Licia Maria Henrique da Mota; Leopoldo Luiz dos Santos Neto; Jozélio Freire de Carvalho
Journal:  Clin Rheumatol       Date:  2009-07-14       Impact factor: 2.980

4.  The ratio of erythrocyte sedimentation rate to C-reactive protein is useful in distinguishing infection from flare in systemic lupus erythematosus patients presenting with fever.

Authors:  E Littlejohn; W Marder; E Lewis; S Francis; J Jackish; W J McCune; E C Somers
Journal:  Lupus       Date:  2018-03-16       Impact factor: 2.911

5.  [Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) : solo or duet?].

Authors:  J G Kuipers; L Köhler
Journal:  Z Rheumatol       Date:  2013-06       Impact factor: 1.372

6.  Serum Adenosine Deaminase as Inflammatory Marker in Rheumatoid Arthritis.

Authors:  Kiranmayi S Vinapamula; Srinivasarao V L N Pemmaraju; Siddartha Kumar Bhattaram; Aparna R Bitla; Suchitra M Manohar
Journal:  J Clin Diagn Res       Date:  2015-09-01

7.  Distinct expression of chemokine-like factor 1 in synovium of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.

Authors:  Ke Tao; Xu Tang; Bin Wang; Ru-Jun Li; Bao-Qing Zhang; Jian-Hao Lin; Hu Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-02-03

8.  Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity.

Authors:  Jeffrey R Curtis; Annette H van der Helm-van Mil; Rachel Knevel; Tom W Huizinga; Douglas J Haney; Yijing Shen; Saroja Ramanujan; Guy Cavet; Michael Centola; Lyndal K Hesterberg; David Chernoff; Kerri Ford; Nancy A Shadick; Max Hamburger; Roy Fleischmann; Edward Keystone; Michael E Weinblatt
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-12       Impact factor: 4.794

9.  Biosynthesis of gold nanoparticles for the treatment of osteoarthritis alone or in combination with Diacerein® in a rat model.

Authors:  Manal A Abdel-Aziz; Helmy M S Ahmed; Aziza A El-Nekeety; Hafiza A Sharaf; Sekena H Abdel-Aziem; Mosaad A Abdel-Wahhab
Journal:  Inflammopharmacology       Date:  2021-06-11       Impact factor: 4.473

10.  Development of a multi-biomarker disease activity test for rheumatoid arthritis.

Authors:  Michael Centola; Guy Cavet; Yijing Shen; Saroja Ramanujan; Nicholas Knowlton; Kathryn A Swan; Mary Turner; Chris Sutton; Dustin R Smith; Douglas J Haney; David Chernoff; Lyndal K Hesterberg; John P Carulli; Peter C Taylor; Nancy A Shadick; Michael E Weinblatt; Jeffrey R Curtis
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.